A Call for Higher Standards for Breast Implants, JAMA: The Journal of the American Medical Association, vol.270, issue.21, pp.2607-2608, 1993. ,
DOI : 10.1001/jama.1993.03510210093034
Breast Cancer -Diagnosis and Treatment, 1987. ,
Heterogeneity of intraductai carcinoma of the breast, Cancer, vol.2, issue.4, pp.731-741, 1989. ,
DOI : 10.1002/1097-0142(19890215)63:4<731::AID-CNCR2820630422>3.0.CO;2-#
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (Intraductal Carcinoma) of the breast, International Journal of Radiation Oncology*Biology*Physics, vol.30, issue.1, pp.3-9, 1994. ,
DOI : 10.1016/0360-3016(94)90512-6
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment, Cancer, vol.28, issue.8, pp.2532-2542, 1993. ,
DOI : 10.1002/1097-0142(19930415)71:8<2532::AID-CNCR2820710817>3.0.CO;2-0
Axillary lymphadenectomy for intraductal carcinoma of the breast, Surgery, Gynecology and Obstetrics, vol.172, issue.3, pp.211-214, 1991. ,
The role of excision and surveillance alone in subclinical DCIS of the breast, Oncology (Huntington NY), vol.8, issue.2, pp.21-35, 1994. ,
Cancer in the Contralateral Breast after Radiotherapy for Breast Cancer, New England Journal of Medicine, vol.326, issue.12, pp.781-785, 1992. ,
DOI : 10.1056/NEJM199203193261201
Dose to the contralateral breast due to primary breast irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.11, issue.3, pp.485-497, 1985. ,
DOI : 10.1016/0360-3016(85)90179-8
Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection., Radiology, vol.183, issue.1, pp.201-206, 1992. ,
DOI : 10.1148/radiology.183.1.1312733
Lobular Carcinoma In Situ of the Breast, The Breast Journal, vol.127, issue.5, pp.285-301, 1987. ,
DOI : 10.1002/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.3.CO;2-R
Risk of infiltrating breast cancer subsequent to lobular carcinoma in situ, Tumori, vol.78, issue.4, pp.244-246, 1992. ,
Adjuvant Breast and Bowel Project: Randomized, Placebo-Controlled Clinical Trial to Determine the Worth of TMX for Preventing Breast Cancer (Summary Last Modified 11/94), NSABP-P-1, clinical trial, active, p.4 ,
The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.18, issue.2, pp.283-287, 1990. ,
DOI : 10.1016/0360-3016(90)90090-7
Results of treating ductal carcinomaIn situ of the breast with conservative surgery and radiation therapy, Cancer, vol.2, issue.1, pp.7-13, 1991. ,
DOI : 10.1002/1097-0142(19910101)67:1<7::AID-CNCR2820670103>3.0.CO;2-B
Duct carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.2, pp.289-292, 1991. ,
DOI : 10.1016/0360-3016(91)90773-W
Radiation therapy for intraductal carcinoma. Is it BRCA2, to chromosome 13q12-13, Science, vol.265, issue.5181, pp.2088-2090, 1994. ,
Genetic Counseling for Families With Inherited Susceptibility to Breast and Ovarian Cancer, JAMA: The Journal of the American Medical Association, vol.269, issue.15, pp.1970-1974, 1993. ,
DOI : 10.1001/jama.1993.03500150082032
Linkage of early-onset familial breast cancer to chromosome 17q21, Science, vol.250, issue.4988, pp.1684-1689, 1990. ,
DOI : 10.1126/science.2270482
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families, American Journal of Human Genetics, vol.52, pp.678-701, 1993. ,
Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer, Breast Cancer Research and Treatment, vol.75, issue.3, pp.147-160, 1986. ,
DOI : 10.1007/BF01806245
Steroid hormone binding and hormone receptors, Cancer Medicine. Philadelphia: Lea & Febiger, pp.815-823, 1993. ,
Neoplasms of the breast, Cancer Medicine. Philadelphia: Lea & Febiger, pp.1706-1716, 1993. ,
Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay., Journal of Clinical Oncology, vol.8, issue.6, pp.1025-1035, 1990. ,
DOI : 10.1200/JCO.1990.8.6.1025
Pathologic findings from the national surgical adjuvant breast and bowel projects (NSABP) prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients, Cancer, vol.100, issue.S9, pp.2121-2128, 1990. ,
DOI : 10.1002/1097-0142(19900501)65:9+<2121::AID-CNCR2820651408>3.0.CO;2-M
Prognosis of breast cancer with axillary node metastases after surgical treatment only, European Journal of Cancer and Clinical Oncology, vol.23, issue.6, pp.795-799, 1987. ,
DOI : 10.1016/0277-5379(87)90281-1
Tumor hormone receptor status and recurrences in premenopausal node negative breast carcinoma, Cancer, vol.309, issue.3, pp.382-385, 1987. ,
DOI : 10.1002/1097-0142(19870801)60:3<382::AID-CNCR2820600316>3.0.CO;2-J
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study., Journal of Clinical Oncology, vol.9, issue.9, pp.1650-1661, 1991. ,
DOI : 10.1200/JCO.1991.9.9.1650
Cathepsin D and Prognosis in Breast Cancer, New England Journal of Medicine, vol.322, issue.5, pp.297-302, 1990. ,
DOI : 10.1056/NEJM199002013220504
Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up., Journal of Clinical Oncology, vol.11, issue.11, pp.2090-2100, 1993. ,
DOI : 10.1200/JCO.1993.11.11.2090
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis, Cancer, vol.2, issue.12, pp.2662-2670, 1986. ,
DOI : 10.1002/1097-0142(19861215)58:12<2662::AID-CNCR2820581219>3.0.CO;2-Y
Importance of Tumor Cells in Axillary Node Sinus Margins (???Clandestine??? Metastases) Discovered by Serial Sectioning in Operable Breast Carcinoma, Acta Oncologica, vol.45, issue.5, pp.483-487, 1988. ,
DOI : 10.1097/00000658-198111000-00005
Suspicious breast lesions: MR imaging with radiologic-pathologic correlation., Radiology, vol.190, issue.2, pp.485-493, 1994. ,
DOI : 10.1148/radiology.190.2.8284404
Age as prognostic factor in premenopausal breast carcinoma*1, The Lancet, vol.341, issue.8852, pp.1039-1043, 1993. ,
DOI : 10.1016/0140-6736(93)92407-K
Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients., Journal of Clinical Oncology, vol.11, issue.10, pp.1929-1935, 1993. ,
DOI : 10.1200/JCO.1993.11.10.1929
Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer, Annals of Internal Medicine, vol.120, issue.1, pp.18-25, 1994. ,
DOI : 10.7326/0003-4819-120-1-199401010-00004
Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States, JNCI Journal of the National Cancer Institute, vol.86, issue.9, pp.705-712, 1994. ,
DOI : 10.1093/jnci/86.9.705
Autosomal Dominant Inheritance of Early-Onset Breast Cancer, Obstetrical & Gynecological Survey, vol.49, issue.6, pp.643-651, 1994. ,
DOI : 10.1097/00006254-199406000-00016
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually, JNCI Journal of the National Cancer Institute, vol.81, issue.24, pp.1879-1886, 1989. ,
DOI : 10.1093/jnci/81.24.1879
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182, pp.66-71, 1994. ,
DOI : 10.1126/science.7545954
Localization of a breast cancer susceptibility gene, 5 References 5.1 References used in this technical report ,
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, vol.152, issue.9, pp.1551-1557, 1983. ,
DOI : 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3
Adjuvant systemic therapy for resectable breast cancer., Journal of Clinical Oncology, vol.3, issue.2, pp.727-742, 1989. ,
DOI : 10.1200/JCO.1985.3.2.259
Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?, Annals of Internal Medicine, vol.111, issue.1, pp.1-4, 1989. ,
DOI : 10.7326/0003-4819-111-1-1
Prognostic factors in breast cancer Principles and practise of oncology, pp.1-11, 1990. ,
Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06., Journal of Clinical Oncology, vol.6, issue.7, pp.1076-1087, 1988. ,
DOI : 10.1200/JCO.1988.6.7.1076
Expression of the erbB-2 family of growth and their ligands in breast cancer, American Journal of Clinical Pathology, vol.102, issue.4, pp.13-23, 1994. ,
International channel of communication for breast cancer literature, International Information, Communication and Education, vol.10, issue.1, pp.48-59, 1991. ,
The psycology of everyday things (Basic Books, 1988. ,
ONCOCIN: An expert system for oncology protocol management, Proceedings IJCAI81, pp.876-881, 1981. ,
Episodic skeletal-plan refinement based on temporal data, Communications of the ACM, vol.32, issue.12, pp.1439-1455, 1989. ,
DOI : 10.1145/76380.76384
BREASTCAN: An expert system for postoperative breast cancer therapy, Computers and Biomedical Research, vol.19, issue.5, 1986. ,
DOI : 10.1016/0010-4809(86)90039-X
14 3.3.1 Definition of prognosis17 3.3.2 Decomposition of prognosis in generic tasks, p.26 ,
30 4.1 A conceptual information retrieval system for the production of guidelines on prognostic factors of breast cancer, p.30 ,
78 9.1 Attended courses and pubblication produced in relation to this work, p.78 ,